Article
Neuroendocrine immunophenotype as predictor of clinical recurrence in 110 patients with prostate cancer.
International journal of immunopathology and pharmacology - 1 Jan 2000
Autorino R, Lamendola M G, De Luca G, De Sio M, Giuliano F, D' Armiento M, De Placido S, Conti P, Di Lorenzo G
Abstract excerpt
We evaluated the relationship between NE expression and well-known prognostic factors and assessed whether tumor relapse after radical surgery correlates with the extent of NE differentiation. Radical prostatectomy specimens from 110 patients with clinically localized prostate cancer were assessed. Patients were followed up every three months for the first two years after surgery and six monthly for 5 additional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.